CD4 and breast carcinoma: Research suggested that gut microbiota may participate in the plasticity of CD4+ T cells in the tumor microenvironment and cause antitumor or tumor-promoting immune responses, thereby exerting anticancer or tumor-promoting effects (39), but the specific signature bacteria that related to the immune function in the breast cancer patients are rarely reported.